Jump to content
TB-500 Prescribed A curated reading of the Thymosin Beta-4 record — what the prescription question actually answers to.

SECTION 05 · THE READING ROOM

An editorial reading of a research peptide

TB-500 Prescribed is a reading room hung with wall labels — here is who writes them and what they will not say.

What this publication is

TB-500 Prescribed reads the published research on Thymosin Beta-4 and its Ac-LKKTETQ fragment the way a gallery hangs its work: each study set on the wall with a plain label beneath it, saying what the piece is, what it shows, and where it came from. It is a reading room, not a clinic or a counter. For all the word 'prescribed' in its name, it writes no prescription and hands out no dose; it sells nothing, supplies nothing, and books no appointment; it keeps no clinicians and gives no medical instruction. What it offers is a captioned, cited walk through what the literature actually reports.

Editorial standards

The labels are written to the record. A quantitative claim appears on a caption only when a specific peer-reviewed study, registered trial, or regulatory document stands behind it, and every source is listed and checkable on /references. Where a finding failed to replicate, the label says so; where animal work has not been shown in people, the label keeps that line clear; where vendor copy blurs the synthetic fragment into full-length Tβ4, the caption restores the distinction the structural biology draws. No seller is linked, and the outbound references go only to PubMed, ClinicalTrials.gov, the NIH, journals, and the agencies of record.

Editorial standards

What this publication isn't

No physician, advisor, or reviewer is named as the hand behind these labels — real or invented — and the publication carries no byline, because it captions the record rather than practicing from it. It prescribes nothing for human use, recommends no treatment, and arranges no consultation, referral, or sale. It does not decide whether obtaining or using this peptide is lawful where a reader lives; that is a matter for a licensed professional who knows the particulars.

How the wall labels read

Each label leads in plain language — what the study asked, what it found, how strong the evidence is — before the technical detail follows, so a reader can take the room at a glance or stop and read closely. The word 'prescribed' in the domain is the framing of the exhibit, the posture the publisher takes toward a much-discussed research peptide, and not an offer to write a script. Nothing on these walls should be mistaken for medical direction.